Besponsa 0.9 mg lyophilized powder for injection Images
Generic Name: inotuzumab ozogamicin
This medication has been identified as Besponsa 0.9 mg lyophilized powder for injection. It is supplied by Pfizer Inc.
Besponsa is used in the treatment of Acute Lymphoblastic Leukemia and belongs to the drug class miscellaneous antineoplastics. Besponsa 0.9 mg lyophilized powder for injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Besponsa
- Generic Name
- inotuzumab ozogamicin
- Strength
- 0.9 mg lyophilized powder for injection
- Availability
- Prescription only
- Drug Class
- Miscellaneous antineoplastics
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Pfizer Inc.
- National Drug Code (NDC)
- 00008-0100
More about Besponsa (inotuzumab ozogamicin)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antineoplastics
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.